Fig. 6From: Worse outcome in breast cancer with higher tumor-infiltrating FOXP3+ Tregs : a systematic review and meta-analysisBegg’s test assessing the FOXP3+ TILs and clinicopathological features such as ER status (a), PR status (b), c-erbB-2 status (c), tumor category (d), lymph node category (e)Back to article page